Sigma-Aldrich Buys Research Organics
The pharmaceutical end-market accounts for 75% of SAFC business, according to a November 2011 company presentation. Research Organics’ products lines include biological buffers, reagent biochemicals, molecular biology grade products, enzyme substrates, fluorescent compounds, amino acids and derivatives, as well as other products, according to its website.
St. Louis, MO 4/2/12—Sigma-Aldrich has acquired Research Organics, a supplier of high-purity biochemicals, for an undisclosed amount. Research Organics joins Sigma-Aldrich’s SAFC business. “Research Organics is an important addition to our pharmaceutical grade portfolio of raw materials for the biopharmaceutical industry,” commented SAFC President Gilles Cottier. “It will also enable us to provide SAFC’s customers with true dual sourcing of buffers from two of the world’s leading manufacturing sites.” The acquisition is expected to be neutral to 2012 EPS.
